Whole‐exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late
暂无分享,去创建一个
T. Pippucci | V. Carelli | B. Mostacci | F. Bisulli | L. Licchetta | P. Tinuper | M. Seri | F. Toni | Luca Bergonzini | C. Stipa | R. Minardi | Giulia Severi | M. C. Baroni
[1] M. Alfadhel,et al. Genomic testing and counseling: The contribution of next‐generation sequencing to epilepsy genetics , 2020, Annals of human genetics.
[2] C. Steward,et al. A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability , 2020, European Journal of Human Genetics.
[3] A. Munnich,et al. Primrose syndrome: a phenotypic comparison of patients with a ZBTB20 missense variant versus a 3q13.31 microdeletion including ZBTB20 , 2020, European Journal of Human Genetics.
[4] A. Poduri,et al. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort , 2020, Epilepsia.
[5] F. Santorelli,et al. Customized multigene panels in epilepsy: the best things come in small packages , 2019, neurogenetics.
[6] Kiely N. James,et al. Bi-allelic Loss of Human APC2, Encoding Adenomatous Polyposis Coli Protein 2, Leads to Lissencephaly, Subcortical Heterotopia, and Global Developmental Delay. , 2019, American journal of human genetics.
[7] Michael R. Johnson,et al. Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals , 2019, bioRxiv.
[8] R. Pfundt,et al. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability , 2018, Epilepsia.
[9] Deciphering Developmental Disorders Study,et al. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias , 2018 .
[10] Klaus Lehnert,et al. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. , 2018, American journal of human genetics.
[11] D. Dyment,et al. Epilepsy genetics: Current knowledge, applications, and future directions , 2018, Clinical genetics.
[12] R. Mcfarland,et al. Overview of Approaches to Mitochondrial Disease Therapy , 2018 .
[13] Edouard Hirsch,et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.
[14] R. Płoski,et al. New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre , 2016, Journal of Translational Medicine.
[15] J. Rivière,et al. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.
[16] J. Conroy,et al. Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion , 2016, Epilepsia.
[17] Z. Nawaz,et al. Loss-of-Function Mutation in APC2 Causes Sotos Syndrome Features. , 2015, Cell reports.
[18] I. Scheffer,et al. Transition to adult life in the monogenic epilepsies , 2014, Epilepsia.
[19] K. Veeramah,et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies , 2013, Epilepsia.
[20] F. Garaci,et al. Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[21] S. Sisodiya,et al. Array comparative genomic hybridization: Results from an adult population with drug-resistant epilepsy and co-morbidities , 2012, European journal of medical genetics.